Life Sciences in Focus: IP, Regulation & Compliance
LSX Investor Perception Survey 2019
In this extract from the LSX Investor Perception Survey 2019, investors share their views on the UK’s decision to exit the EU. We also examine the sway that IP and other factors have over respondents’ investment decisions. The 3rd annual LSX Investor Perception Survey tracks sentiment, aims, and preferences among the life science investment community.
LSX (formerly Biotech and Money) is an influential community of senior life science decision makers. Through our impactful events, powerful thought leadership content and unique networking opportunities, we exist to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.